A federal judge has allowed key claims in Particle Health’s antitrust lawsuit against Epic to move forward, marking the first time such allegations against the EHR giant have gotten this far. The case centers on Epic’s alleged use of its influence over the Carequality data exchange to block Particle’s access to patient records and stifle…
Takeda Pharmaceutical’s oveporexton is designed to treat the root cause of narcolepsy. Statistically significant Phase 3 results for the twice daily pill were presented Monday during the World Sleep 2025 Congress in Singapore. The post Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels appeared first on MedCity…
WeightWatchers’ new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed. The post WeightWatchers Introduces New Menopause Program appeared first on MedCity News.
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Cada año, durante nuestras vacaciones familiares en Cape Cod, disfrutamos de todos los placeres clásicos del verano: escalar dunas, caminar por la playa, observar focas, comer ostras y leer los libros que nos habíamos propuesto durante todo el año. También hacer compras. Mi nieto quería unos juguetes pequeños. Mi hija aprovechó para llevarse varios rompecabezas…
En los últimos años, en la capital de Michigan y sus alrededores, Rebecca Kasen ha visto y oído cosas que nunca habría imaginado. “Estamos viviendo un momento muy extraño”, reflexionó Kasen, directora ejecutiva del Women’s Center of Greater Lansing. Una madrugada de noviembre, una cámara de vigilancia del Women’s Center captó a un grupo de…
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.